Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
223.87
+3.59 (+1.63%)
Streaming Delayed Price
Updated: 1:22 PM EDT, Jul 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Charles River Laboratories Intl
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Evaluating Charles River: Insights From 7 Financial Analysts
March 18, 2024
Via
Benzinga
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
March 14, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Top 3 Healthcare Stocks to Buy in March 2024
March 07, 2024
There are still bargains to be had in the medical space. These are three top healthcare stocks to buy today.
Via
InvestorPlace
Forecasting The Future: 4 Analyst Projections For Charles River
February 15, 2024
Via
Benzinga
Earnings Scheduled For February 14, 2024
February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.
Via
Benzinga
9 Analysts Have This to Say About Charles River
December 11, 2023
Via
Benzinga
Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy?
March 07, 2024
vBitcoin has exploded higher over the past month setting an all-time record. That’s excellent news for Coinbase Global and COIN stock.
Via
InvestorPlace
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
March 06, 2024
Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.
Via
Investor's Business Daily
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
February 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
February 20, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
February 15, 2024
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.
Via
InvestorPlace
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
February 14, 2024
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned
February 14, 2024
Charles River Laboratories Q4 2023 revenue: $1.01 billion, down 7.9% YoY, beating consensus. Analysts note mixed Q4 performance, keeping Outperform rating.
Via
Benzinga
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
February 14, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 14, 2024
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list...
Via
Benzinga
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
January 29, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
January 24, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
January 23, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Ten Big Losers To Start The Year. Tesla Isn't The Worst.
January 16, 2024
Enphase Energy remains out of phase with the stock market.
Via
Investor's Business Daily
Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
January 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
January 08, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
December 18, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
December 12, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Investing in the Aging Population: 3 Healthcare Stocks to Watch
December 07, 2023
America is becoming a much older country on average. These three healthcare stocks are ideally positioned for this demographic shift.
Via
InvestorPlace
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
November 28, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Evercore ISI Investor Conference
November 27, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
The 3 Most Undervalued Tech Stocks to Buy Now: November 2023
November 17, 2023
Growth stocks are rallying but there are still bargains to be found. These three top tech picks can reward long-term investors.
Via
InvestorPlace
Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
November 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
November 13, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.